共 146 条
[1]
Loibl S(2017)Her2-positive breast cancer The Lancet 10087 2415-2429
[2]
Gianni L(2017)Imprint cytology-based breast malignancy screening: an efficient nuclei segmentation technique J Microsc 2 155-171
[3]
Saha M(2017)Near-set based mucin segmentation in histopathology images for detecting mucinous carcinoma J Med Syst 41 1-13
[4]
Arun I(2017)Global cancer in women: burden and trends Cancer Epidemol Biomarkers Prev 26 444-457
[5]
Agarwal S(2021)Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249
[6]
Ahmed R(2015)Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification Genome Biol 16 1-21
[7]
Chatterjee S(2020)Nanotechnology approaches to addressing HER2-positive breast cancer Cancer Nanotechnol 11 1-26
[8]
Chakraborty C(2001)Biology of HER2 and its importance in breast cancer Oncology 61 1-13
[9]
Banerjee S(2014)Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 AND NCCTG N9831 J Clini Oncol 32 3744-1382
[10]
Saha M(2018)Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update Arch Pathol Lab Med 11 1364-1056